• Krabbe Disease (GALC) Gene Mutation Analysis
  • Alprazolam, SerumĀ 
  • CHEK2 Gene Mutation Analysis
  • Special Stain, Congo Red
  • Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • Lupus Anticoagulants
  • Myelin Associated Glycoprotein (MAG) Antibody
  • Branched-chain-ketoacid dehydrogenase (BCKDH) Gene Mutation Analysis
  • T-Cell Antigen Receptor, Beta (TCRB) Gene Rearrangement Analysis for Abnormal Clonality, Applified Method
  • Beta-Glucosidase, Fibroblasts
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Factor XIII (F13A1) V34L Genetic Variation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Factor XIII (F13A1) V34L Genetic Variation Analysis
Medical Test

Turnaround Time
Access to Factor XIII (F13A1) V34L Genetic Variation Analysis is restricted.